Perceptive Advisors LLC Geron Corp Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.52 - $2.1 $20.5 Million - $28.3 Million	-13,461,538 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $11.5 Million - $23.8 Million	10,911,538 Added 427.9%	13,461,538 $29.3 Million
Q2 2018 Nov 01, 2018	BUY	$3.29 - $4.82 $8.39 Million - $12.3 Million	2,550,000 New	2,550,000 $2.92 Million

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.